Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes
2022 · Cardiovascular Diabetology · 31 citations
https://doi.org/10.1186/s12933-022-01519-3